Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT01721447
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT01721447
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01721447. Allocation not applicable; no masking; primary purpose diagnostic. Start 2013-06 (registry gives no type); primary completion 2018-05 (actual). Results posted on 2019-06-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage
- Acronym
- DOLOP
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Optison echocardiography contrast agent
- Lead sponsor
- University of Utah
Record details
- Record id
cardio:ct-nct01721447- Content hash
988f7e995f84a3153708bd6b868a082105734faa30df9910a3c7cdb36f09ba61